Login

BlackRock Favors Japan Stocks | Hiroyuki Shimizu, CEO, BlackRock Japan Co. Ltd.AS OF 07 MAR 2024 00:10:00

Share On Facebook Share On Twitter

Hiroyuki Shimizu is the CEO of BlackRock Japan Co. Ltd.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Great Atlantic Salt: Low-Cost, Scalable Mining Opportunity
00:10:00
Inheriting Prosperity: Inside The Wealth Conservancy | MYRA SALZER - CFP of The Wealth Conservancy, Inc.
00:10:00
private equity deals focused on emerging restaurants beverages services|Don Thompson,CEO,Cleveland Avenue
00:10:00
Mastering Business Networking: Insights with Tom Zimmerman and Dr. Michael Cortese - Tom Zimmerman | Founder | Zimmerman Wealth Management
00:10:00
V-Zug CEO Peter Spirig Discusses Company Vision and Innovations at Industry Event | Peter Spirig, CEO , V-Zug Holding AG.
00:10:00
Aotearoa's Biggest Airport Set for Revamp: What It Means for Us All | Carrie Hurihanganui - CEO of auckland international airport ltd
00:10:00
Interim Report Update: Genova Property Group’s Performance and Future Outlook | Michael Moschewitz, CEO , Genova Property Group AB.
00:10:00
The Importance of Global Collaboration in Energy Decarbonization | Pat Vincent-Collawn, CEO , PNM Resources Inc.
00:10:00
Hartford CEO Christopher J. Swifton Economic Outlook, Inflation, and California's Regulatory Challenges | Christopher J. Swift, CEO , The Hartford.
00:10:00
Michael Doss CEO of Graphic Packaging recently invested $600 million in a new facility here in Kalamazoo
00:10:00
Andrew Pegge Thurman discusses the Goongarrie Nickel Cobalt Project and Exploration Strategy
00:10:00
Comprehensive Financial Planning with Joni Lindquist | Joni Lindquist, Principal, Aspyre Wealth Partners.

© 2026 Nehu